Investors overview
Agios is a biopharmaceutical company that is fueled by connections. The strong bonds we build with patient communities, partners and colleagues enrich the impact we have as experts in cellular metabolism and enhance our collaboration, creativity and productivity – driving our ability to develop life-changing treatments for patients with rare diseases.
Stock Information
Volume:
Minimum 15 minutes delayed. Source:
-
Latest Earnings Call View Replay
-
Latest Form 10-K View PDF
-
Email Alerts Sign Up
-
Corporate Fact Sheet View PDF
-
Corporate Responsibility View PDF